Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Griet Compernolle

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Crohn'S & Colitis|February 5, 2019
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission RatesBram Verstockt, Erwin Dreesen, Maja Noman, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed labelSebastian Stefanovic, Iris Detrez, Griet Compernolle, et al.
Frontiers in Oncology|October 20, 2022
Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep modelKevin Hollevoet, Debby Thomas, Griet Compernolle, et al.
Analytical Chemistry|August 5, 2016
Bioassay Development for Ultrasensitive Detection of Influenza A Nucleoprotein Using Digital ELISAKaren Leirs, Phalguni Tewari Kumar, Deborah Decrop, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's diseaseDavid Drobne, Peter Bossuyt, Christine Breynaert, et al.
Journal of Molecular Biology|March 22, 2017
Prediction and Reduction of the Aggregation of Monoclonal AntibodiesRob van der Kant, Anne R Karow-Zwick, Joost Van Durme, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Crohn'S & Colitis|February 5, 2019
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission RatesBram Verstockt, Erwin Dreesen, Maja Noman, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed labelSebastian Stefanovic, Iris Detrez, Griet Compernolle, et al.
Frontiers in Oncology|October 20, 2022
Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep modelKevin Hollevoet, Debby Thomas, Griet Compernolle, et al.
Analytical Chemistry|August 5, 2016
Bioassay Development for Ultrasensitive Detection of Influenza A Nucleoprotein Using Digital ELISAKaren Leirs, Phalguni Tewari Kumar, Deborah Decrop, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's diseaseDavid Drobne, Peter Bossuyt, Christine Breynaert, et al.
Journal of Molecular Biology|March 22, 2017
Prediction and Reduction of the Aggregation of Monoclonal AntibodiesRob van der Kant, Anne R Karow-Zwick, Joost Van Durme, et al.
Pageof 3